Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [543]
News [1577]
Articles [79]
Editorials [2]
Conferences [74]
elearning [5]

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief
Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )
16 Jun 2016

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA
Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )
4 May 2016

Understanding personalised medicine - the e-learning course

Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016

SPF30 sunscreens delay melanoma incidence in preclinical model

Dr Christin Burd - Ohio State University, Columbus, USA
SPF30 sunscreens delay melanoma incidence in preclinical model ( Dr Christin Burd - Ohio State University, Columbus, USA )
26 Apr 2016

T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy

Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy ( Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany )
4 Apr 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor
What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )
23 Dec 2015

Drug resistance mechanisms

Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands
Drug resistance mechanisms ( Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands )
22 Dec 2015

Immunotherapy makes patients’ tumours "melt away"

Dr Joshua Brody - Mount Sinai Medical Center, New York, USA
Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )
6 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation